The blood concentration of irisin is significantly altered in patients suffering from acute coronary syndrome, especially in myocardial infarction (AMI), ST-Elevation Myocardial Infarction (STEMI) and stable coronary disease. This evidence concerns the gene FNDC5 and myocardial infarction.